Adam F Kemp
Overview
Explore the profile of Adam F Kemp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hojlund M, Kohler-Forsberg O, Gregersen A, Rohde C, Mellentin A, Anhoj S, et al.
Lancet Psychiatry
. 2024 Nov;
11(12):975-989.
PMID: 39547246
Background: Antipsychotic polypharmacy remains a clinical reality, despite an increased risk of adverse events and little evidence of additional efficacy compared with antipsychotic monotherapy. In this systematic review and meta-analysis,...
2.
Kohler-Forsberg O, Hojlund M, Rohde C, Kemp A, Gregersen A, Mellentin A, et al.
Schizophr Res
. 2024 Jun;
270():135-143.
PMID: 38908279
Background: Antipsychotic polypharmacy (APP) is frequent but evidence-based guidelines on reducing APP to antipsychotic monotherapy (APM) are sparse. We aimed to systematically review clinical interventions randomizing patients to reducing APP...
3.
Kemp A, Kinnerup M, Johnsen B, Jakobsen S, Nahimi A, Gjedde A
Biomolecules
. 2024 Feb;
14(2).
PMID: 38397446
Introduction: Increased theta and delta power and decreased alpha and beta power, measured with quantitative electroencephalography (EEG), have been demonstrated to have utility for predicting the development of dementia in...
4.
Kemp A, Bentz M, Olsen E, Moslet U, Plessen K, Koch S
Int J Eat Disord
. 2023 Jun;
56(10):1866-1874.
PMID: 37365947
Objective: The objective of this study was to investigate the predictive value of sex, age, body mass index (BMI), Eating Disorder Examination (EDE) score, social risk factors, and psychiatric comorbidities...
5.
Hojlund M, Kemp A, Haddad P, Neill J, Correll C
Lancet Psychiatry
. 2021 Aug;
8(9):748-749.
PMID: 34419176
No abstract available.
6.
Hojlund M, Kemp A, Haddad P, Neill J, Correll C
Lancet Psychiatry
. 2021 May;
8(6):471-486.
PMID: 34023019
Background: Dose reduction of antipsychotic maintenance treatment in individuals with schizophrenia could be desirable to minimise adverse effects, but evidence for this strategy is unclear. We aimed to compare risks...